George Matcham
Directeur/Bestuurslid bij INSTIL BIO, INC.
Vermogen: 419 269 $ op 31-05-2024
Actieve functies van George Matcham
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INSTIL BIO, INC. | Directeur/Bestuurslid | 01-09-2018 | - |
| Independent Dir/Board Member | 01-09-2018 | - |
Loopbaan van George Matcham
Eerdere bekende functies van George Matcham
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Directeur/Bestuurslid | 05-07-2021 | 03-08-2023 |
| CELGENE | Corporate Officer/Principal | 01-05-2013 | 01-06-2018 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Operationeel Directeur | - | - |
Opleiding van George Matcham
| University of Cardiff | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Verenigd Koninkrijk | 3 |
| Australië | 2 |
Operationeel
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- George Matcham
- Ervaring
